Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 4/20 | 0.44 |
| ▸ | F2 | P00734 | 5/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGAV | P06756 | 1/20 | 0.44 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | CALCR | P30988 | 2/20 | 0.40 |
| ▸ | NTMT1 | Q9BV86 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29569112 | 0.98 | APLNR (0.43) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29568535 | 0.95 | APLNR (0.49) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29569060 | 0.94 | ITGB3 (0.48) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29568833 | 0.94 | ITGB3 (0.48) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29568907 | 0.93 | ITGB3 (0.46) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29568606 | 0.92 | APLNR (0.53) | APLNRITGB3ITGAVC5AR1 | |
| SCHEMBL29568777 | 0.91 | APLNR (0.51) | APLNRC5AR1 | |
| SCHEMBL29569494 | 0.91 | APLNR (0.47) | APLNRF2ITGB3ITGAVC5AR1 | |
| SCHEMBL29569960 | 0.91 | CALCRL (0.38) | APLNRF2ITGB3ITGAVOPRM1 | |
| SCHEMBL29569026 | 0.90 | APLNR (0.46) | APLNRF2ITGB3ITGAVCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3320923-B1 | FLUORESCENT IMAGING AGENTS | VISEN MEDICAL INC (US) | 2022-04-06 | — | — | EP | claimed |
| EP-3320923-B1 | FLUORESCENT IMAGING AGENTS | VISEN MEDICAL INC (US) | 2022-04-06 | — | — | EP | disclosed |